PLAU and head and neck squamous cell carcinoma: More importantly, based on TCGA dataset, our clinical experiments proved that a set of prognostic signatures including SERPINE1, PLAU and ACTA1 were identified as biomarkers for diagnosis and prognosis of HNSCC, which may provide novel insights for unraveling pathogenesis of HNSCC.